Raymond W. Nims, PhD, is a biosafety consultant at RMC Pharmaceutical Solutions, Inc.
The authors present a case study identifying a contaminant.
What you need to know about USP chapter <63>.
Avoid manufacturing failures by effective viral inactivation.
Strategies for accurate speciation and case studies for the detection of cell line cross-contamination using a commercial kit.